Search Results 71-80 of 18228 for Hepatitis C

  1. Peginterferon alfa-2a (subcutaneous route) - Mayo Clinic

    ... hepatitis C infection in patients who are not able to take other medicine. It is also used to treat chronic hepatitis B infection. Peginterferon alfa-2a is ...

  2. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  3. The Making of an Expert - Mayo Clinic News Network

    Hepatitis C is spread by blood and becomes a long-term, chronic infection for 70% to 85% of infected people. Chronic hepatitis C can result in long-term health ...

  4. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Age ≥ 18 years · Previously undergone orthotopic liver transplant (OLT) at least 2 months prior to the planned start of dosing · Aggressive Hepatitis C infection ...

  5. Boceprevir (oral route) - Mayo Clinic

    ... hepatitis C infection. These medicines are used in patients with compensated liver disease (including cirrhosis), who have not been treated before or who ...

  6. 4/16/16 #MayoClinicRadio Podcast: Hep C, Food Allergies, Hemorrhoids - Mayo Clinic News Network

    On Mayo Clinic Radio, infectious diseases specialist Dr. Stacey Rizza outlines the risk factors for contracting hepatitis C, especially for people born between ...

  7. Mayo Clinic Minute: ABCs of hepatitis VIDEO AUDIO Approximately 5.3 million people in the US have hepatitis. Stacey Rizza, M.D.

    a chronic infection, and we're fortunate that we have a very, very effective vaccine for hepatitis B.” Hepatitis C is transmitted from person to person ...

  8. Cirrhosis - Diagnosis and treatment - Mayo Clinic

    Medicines to control hepatitis. Medicines may limit further damage to liver cells caused by hepatitis B or C through specific treatment of these viruses.

  9. Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C: Mayo Clinic Radio

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...

  10. A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis - Mayo Clinic

    A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and ...